Literature DB >> 6142986

A withdrawal hyperalgesia test for physical dependence: evaluation of mu and mixed-partial opioid agonists.

P F VonVoigtlander, R A Lewis.   

Abstract

The physical dependence-inducing properties of analgesics are commonly assessed by the appearance of typical narcotic withdrawal signs (weight loss, jumping, etc.) upon cessation of administration or treatment with a narcotic antagonist. We sought to develop a simple model of physical dependence based upon withdrawal hyperalgesia. The test compound was injected seven times over a period of three days. At various times after the last injection, 6% aqueous NaCl was injected i.p. and the mice were observed for stereotyped writhing. To assess the magnitude of hyperalgesia, the animals were also challenged with several concentrations of saline administered at the time of peak sensitivity and a saline EC50 was thereby derived. In this manner, it was demonstrated that morphine causes a marked, dose-related physical dependence. Other mixed opioids, pentazocine, ethylketocyclazocine, nalbuphine, and butorphanol (in decreasing order of effectiveness) were also active. In nonpretreated mice, naloxone caused a dose-related appearance of saline-induced writhing, suggestive of a blockade of endogenous analgesic mechanisms. Writhing in response to low concentrations of i.p. saline provides a sensitive test of analgesic physical dependence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6142986     DOI: 10.1016/0160-5402(83)90022-0

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  5 in total

1.  Altered quantitative sensory testing outcome in subjects with opioid therapy.

Authors:  Lucy Chen; Charlene Malarick; Lindsey Seefeld; Shuxing Wang; Mary Houghton; Jianren Mao
Journal:  Pain       Date:  2009-02-23       Impact factor: 6.961

2.  From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.

Authors:  Larry F Chu; De-Yong Liang; Xiangqi Li; Peyman Sahbaie; Nicole D'arcy; Guochun Liao; Gary Peltz; J David Clark
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

3.  Clinical evaluation of analgesic activity of guduchi (tinospora cordifolia) using animal model.

Authors:  Bhomik Goel; Nishant Pathak; Dwividendra Kumar Nim; Sanjay Kumar Singh; Rakesh Kumar Dixit; Rakesh Chaurasia
Journal:  J Clin Diagn Res       Date:  2014-08-20

4.  PMSF Attenuates Morphine Antinociceptive Tolerance and Dependence in Mice: Its Association with the Oxidative Stress Suppression.

Authors:  Ehsan Asadi Akbarabadi; Hossein Rajabi Vardanjani; Shahrzad Molavinia; Marzieh Pashmforoosh; Mohammad Javad Khodayar
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

5.  Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report.

Authors:  Joshua MacAusland-Berg; Amy Wiebe; Radhika Marwah; Katelyn Halpape
Journal:  Can J Pain       Date:  2022-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.